Sep 2026· Zenodo (CERN European Organization for Nuclear Research)
Pharmacy and Medical Practices
Abstract
厚生労働省の社会医療診療行為別統計(令和7年8月審査分)の、薬局調剤の第6表と医科診療の第17表で、明細書 1 件に出てくる薬の種類の数が年齢とともにどう広がるかを見た。 薬局の内服薬で、明細書 1 件当たりの薬剤種類数は 20〜24 歳の 2.66 がいちばん少なく、90 歳以上は 5.49(2.064 倍)である。ところが 10 種類以上の割合は 0.0064 から 0.1339(20.97 倍)、5 種類以上の割合は 3.912 倍になる。10 種類以上の割合は 20〜24 歳から 90 歳以上までどの 5 歳階級でも上がり、10 種類以上の件数の 0.628 は 75 歳以上の明細書である。院内処方(医科・入院外・投薬)でも、平均 1.869 倍に対して 10 種類以上 15.12 倍と同じ形になる。分けるのは、平均で見るか、分布の端で見るかである。 本稿は公開の集計データの数の形を述べる構造的解釈であり、医学的な助言・診断・治療の推奨ではない。著者は医師ではない。個人の健康に関する判断は医師・医療機関に相談すること。査読を経ていないプレプリントである。新しい数学定理も新しい法則も主張しない。薬の数の多い少ないの良し悪し、処方の良し悪し、薬を減らすべきかどうかには立ち入らない。「5 種類以上」「10 種類以上」は表の階級の区切りとして使うだけである。薬を飲んでいる人や、薬を出す医師・薬局を責めるものではない。件数は明細書の件数で人の数ではない。都道府県・薬局・医療機関は比べない。一人の見通しではない。出典:社会医療診療行為別統計(厚生労働省・e-Stat)を加工して作成。 作成にあたって:本稿の着想と内容は、著者自身の考察に基づくものです。文章の構成整理や英訳、数式の確認には AI(大規模言語モデル)の助力を得ました。最終的な内容の解釈や誤りがあれば、それらはすべて著者の責に帰します。お気づきの点があれば、ご教示いただければ幸いです。 ----- Using the Ministry of Health, Labour and Welfare's Statistics of Medical Care Activities in Public Health Insurance (claims reviewed in August 2025), Pharmacy Table 6 and Medical Care Table 17, this paper looked at how the number of drug types on one statement spreads with age. For pharmacy oral drugs, drug types per statement are fewest at 20–24, 2.66, and 5.49 at 90+ (2.064-fold). Yet the share with 10 or more types goes from 0.0064 to 0.1339 (20.97-fold), and the share with 5 or more rises 3.912-fold. The share with 10 or more rises in every five-year group from 20–24 to 90+, and 0.628 of statements with 10 or more types are at 75+. In-clinic dispensing (medical care, outpatient, medication) shows the same shape, 1.869-fold in the mean against 15.12-fold for 10 or more. What separates them is whether one looks at the mean or at the tail of the distribution. This paper is a structural interpretation of the shape of numbers in public aggregate data; it is not medical advice, not a diagnosis, and not a treatment recommendation. The author is not a physician. Decisions about individual health should be discussed with a physician or a medical institution. This is a preprint that has not been peer reviewed. No new mathematical theorem and no new law are claimed. It does not judge whether many or few drugs are good or bad, whether prescribing is good or bad, or whether drugs should be reduced; "5 or more" and "10 or more" are used only as the brackets of the tables. It does not blame people who take drugs, nor the physicians or pharmacies who provide them. Counts are statements, not people. Prefectures, pharmacies, and institutions are not compared. It is not an outlook for any one person. Source: processed from the Statistics of Medical Care Activities in Public Health Insurance (Ministry of Health, Labour and Welfare, e-Stat). On the making of this work: The ideas and content of this work stem from the author's own considerations. Assistance from an AI (a large language model) was used for structuring, English translation, and checking the algebra. Any remaining errors or misinterpretations are solely the author's. Feedback and corrections are sincerely appreciated.
The results are packaged in the Greenfield Startup Model (GSM), which explains the priority of startups to release the product as quickly as possible, and the need to shorten time-to-market, by speeding up the development through low-precision engineering activities.
Carmine Giardino, Nicolò Paternoster, M. Unterkalmsteiner et al.· IEEE Transactions on Softwar...· 178 citations· ⚡14
Software startup companies develop innovative, software-intensive products within limited timeframes and with few resources, searching for sustainable and scalable business models.
M. Unterkalmsteiner, P. Abrahamsson, Xiaofeng Wang et al.· e-Informatica Software Engin...· 157 citations· ⚡17
This study conducts a case survey study based on the secondary data of the major pivots happened in 49 software startups, and demonstrates that customer need pivot is the most common among all pivot types.
Sohaib Shahid Bajwa, Xiaofeng Wang, Anh Nguyen-Duc et al.· Empirical Software Engineeri...· 127 citations· ⚡15
The comparison of adopter and non-adopter sample reveals three potential adoption inhibitor, security, data privacy, and portability, which underlines the importance of the technical and security perspectives for research investigating the adoption of technology.
Nattakarn Phaphoom, Xiaofeng Wang, S. Samuel et al.· Journal of Systems and Softw...· 111 citations· ⚡8
The ongoing work building a Raspberry Pi cluster consisting of 300 nodes is presented, with potential use cases being an inexpensive and green test bed for cloud computing research and a robust and mobile data center for operating in adverse environments.
P. Abrahamsson, S. Helmer, Nattakarn Phaphoom et al.· IEEE International Conferenc...· 110 citations· ⚡7
The results indicate that software developers are a slightly happy population, but the need for limiting the unhappiness of developers remains, and 219 factors representing causes of unhappiness while developing software are identified.
D. Graziotin, Fabian Fagerholm, Xiaofeng Wang et al.· International Conference on...· 84 citations· ⚡6
Related blog posts
Microsoft Research Blog· microsoft.comOct 12, 2026
StudentSim is a research system for evaluating and improving AI tutoring tools before they are tested with learners. It models how individuals may engage with tutors, giving feedback to improve tutor performance across subjects like chess, writing, and mathematics. The post Simulating student learning for better AI tutoring appeared first on Microsoft Research.
MIT News · Artificial Intelligence· news.mit.eduOct 8, 2026